BHLH149 Antibody is hypothesized to target a protein within the BHLH family, which regulates gene expression critical for cellular differentiation, development, and stress responses. While no specific studies on this antibody exist, BHLH proteins are well-studied targets in oncology, neurology, and inflammatory diseases. Monoclonal antibodies (mAbs) like BHLH149 are engineered to bind specific epitopes, enabling precise therapeutic or diagnostic interventions .
Monoclonal antibodies (mAbs) are engineered proteins that bind to specific antigens, enabling targeted therapies. Key mechanisms include:
If BHLH149 targets a BHLH protein, its applications could align with the following research trends:
Cancer: BHLH transcription factors (e.g., Twist1, HIF-1α) regulate metastasis and hypoxia responses. Neutralizing these could suppress tumor progression .
Neurological Disorders: BHLH proteins control neuronal differentiation; dysregulation may contribute to neurodegenerative diseases .
Inflammation: BHLH factors modulate immune cell activation, making them candidates for autoimmune therapies .
Biomarker Detection: Anti-BHLH antibodies could identify protein expression levels in tissues or biofluids, aiding disease prognosis or monitoring .
Modern mAbs are optimized for efficacy and safety:
BHLH149’s specificity would be tested via Western blotting (WB), where antibodies detect target proteins in lysates or tissues. A molecular weight marker (e.g., M&R LE) ensures accurate size determination .
Antigen Heterogeneity: BHLH proteins may exhibit post-translational modifications, reducing antibody binding efficacy.
Off-Target Effects: Cross-reactivity with homologous BHLH proteins could cause unintended toxicity.
Pharmacokinetics: Suboptimal FcRn binding may limit serum persistence, necessitating frequent dosing .
BHLH149 is a basic helix-loop-helix transcription factor (Uniprot No. O80482) found in Arabidopsis thaliana. This protein belongs to a family of transcription factors that regulate various developmental processes and stress responses in plants. Antibodies against BHLH149 are important research tools because they allow scientists to:
Track the spatial and temporal expression patterns of the protein across different tissues and developmental stages
Investigate protein-protein interactions involving BHLH149
Assess post-translational modifications that might regulate BHLH149 activity
Validate genetic experiments through protein detection methods
The availability of specific antibodies against plant proteins like BHLH149 is critical for advancing our understanding of plant molecular biology, particularly as we move toward more integrative systems biology approaches that require knowledge of protein localization and interaction networks .
BHLH149 antibodies have been specifically validated for enzyme-linked immunosorbent assay (ELISA) and Western Blotting (WB) applications. These validation processes ensure that the antibody reliably detects the target protein in these specific experimental contexts . The applications include:
Western Blotting (WB): For detecting BHLH149 protein in plant tissue extracts and determining its molecular weight, expression levels, and potential modifications.
ELISA: For quantitative analysis of BHLH149 protein levels in solution.
It's important to note that these antibodies have not been validated for other common applications such as immunoprecipitation (IP), chromatin immunoprecipitation (ChIP), immunohistochemistry (IHC), or immunofluorescence (IF). Researchers wishing to use the antibody for these applications would need to perform their own validation experiments .
Proper storage and handling of BHLH149 antibodies are crucial for maintaining their activity and specificity. Based on manufacturer recommendations, the following protocols should be followed:
Storage Temperature: Upon receipt, store at -20°C or -80°C to preserve antibody activity and prevent degradation .
Avoid Freeze-Thaw Cycles: Repeated freezing and thawing can denature antibodies and reduce their effectiveness, so aliquoting before storage is recommended.
Storage Buffer: The antibodies are supplied in a liquid form with a storage buffer containing 0.03% Proclin 300 as a preservative, 50% Glycerol, and 0.01M PBS at pH 7.4 .
Working Dilutions: Optimal dilutions must be determined experimentally but typically range from 1:500 to 1:2000 for Western blotting applications.
For long-term storage, maintaining a stable temperature is critical. Any antibody solution removed for immediate use should be kept on ice during the experimental procedure to minimize degradation.
Commercial BHLH149 antibodies have specific characteristics that researchers should consider when selecting them for experiments:
| Specification | Details |
|---|---|
| Product Code | CSB-PA530499XA01DOA |
| Host Species | Rabbit |
| Target Species | Arabidopsis thaliana |
| Clonality | Polyclonal |
| Immunogen | Recombinant Arabidopsis thaliana BHLH149 protein |
| Purification Method | Antigen Affinity Purified |
| Isotype | IgG |
| Format | Liquid, Non-conjugated |
| Applications | ELISA, Western Blot |
| Lead Time | 14-16 weeks (made-to-order) |
| Usage Restrictions | Research Use Only, not for diagnostic or therapeutic procedures |
This polyclonal antibody was generated by immunizing rabbits with recombinant BHLH149 protein and subsequently purified using antigen affinity methods, which enhances its specificity for the target protein .
Optimizing Western blotting protocols for BHLH149 detection requires careful consideration of several experimental parameters:
Sample Preparation:
Extract proteins from Arabidopsis tissues using a buffer containing protease inhibitors to prevent degradation
Consider using phosphatase inhibitors if investigating phosphorylation status
Optimize protein loading (typically 20-50 μg total protein per lane)
Electrophoresis and Transfer:
Use 10-12% SDS-PAGE gels for optimal resolution of BHLH149 (molecular weight should be verified)
Transfer proteins to PVDF membranes (preferred over nitrocellulose for plant proteins)
Use wet transfer for higher molecular weight proteins or semi-dry for faster protocols
Antibody Incubation:
Begin with a 1:1000 dilution in 5% non-fat dry milk or BSA in TBST
Perform titration experiments (1:500, 1:1000, 1:2000, 1:5000) to determine optimal concentration
Incubate with primary antibody overnight at 4°C for best results
Use an appropriate HRP-conjugated secondary antibody (anti-rabbit IgG)
Detection Optimization:
Use enhanced chemiluminescence (ECL) detection systems
Consider longer exposure times if signal is weak
For quantitative analysis, ensure the signal is within the linear range
This optimization approach has been shown to significantly improve detection rates in plant antibody research, similar to the methods reported for other Arabidopsis proteins .
Rigorous experimental design requires appropriate controls when working with BHLH149 antibodies:
Positive Controls:
Recombinant BHLH149 protein (if available)
Extracts from tissues known to express BHLH149 (based on transcriptomic data)
Overexpression lines of BHLH149 in Arabidopsis or heterologous systems
Negative Controls:
Extracts from bhlh149 knockout/knockdown mutant plants
Pre-immune serum control (at the same dilution as the primary antibody)
Secondary antibody-only control (omitting primary antibody)
Blocking peptide competition assay (pre-incubating antibody with immunizing peptide)
Additional Validation Controls:
Testing antibody specificity against related BHLH family members
Cross-reactivity assessment with proteins from non-target species
Validation across multiple experimental replicates and biological samples
Implementation of these controls follows best practices demonstrated in plant antibody research, where affinity purification and thorough validation significantly improved detection confidence rates from less than 20% to over 55% .
Although BHLH149 antibodies have not been specifically validated for immunolocalization techniques, they could potentially be adapted for these applications with appropriate optimization and validation:
Immunocytochemistry Optimization Strategy:
Fixation protocol development:
Test different fixatives (4% paraformaldehyde, glutaraldehyde combinations)
Optimize fixation times (15 min to 2 hours)
Evaluate various embedding mediums for plant tissues
Antigen retrieval methods:
Heat-induced epitope retrieval (citrate buffer, pH 6.0)
Enzymatic antigen retrieval (proteinase K treatment)
Testing different concentrations and incubation times
Signal amplification:
Tyramide signal amplification
Avidin-biotin complex (ABC) method
Fluorophore-conjugated secondary antibodies of varying brightness
Validation approaches:
Co-localization with known nuclear markers (for transcription factors)
Comparison with fluorescent protein fusion localization patterns
Absence of signal in knockout mutants
This methodological approach is based on successful strategies used for other plant proteins, where approximately 31% of generated antibodies were successfully developed to immunocytochemistry grade through similar optimization steps .
Developing effective antibodies against plant transcription factors presents several unique challenges:
Technical Challenges:
Low abundance: Transcription factors typically exist in low quantities within cells, making detection difficult
Conservation: High sequence similarity between related BHLH family members can lead to cross-reactivity issues
Conformational epitopes: Native protein folding may present different epitopes than those recognized in denatured WB conditions
Post-translational modifications: PTMs may mask epitopes or create new ones in vivo
Strategic Solutions:
Immunogen design optimization:
Use unique peptide sequences specific to BHLH149
Develop recombinant proteins with correctly folded domains
Consider multiple immunization strategies in parallel
Purification approaches:
Implement rigorous affinity purification protocols
Use negative selection against related family members
Perform epitope mapping to characterize antibody binding sites
Validation thoroughness:
Test against multiple plant tissues and developmental stages
Validate across different experimental techniques
Perform cross-reactivity tests with related BHLH proteins
This challenging landscape is reflected in plant antibody development success rates, where comprehensive studies have shown that only about 55% of antibodies raised against plant proteins successfully detect their targets with high confidence, and even fewer (approximately 31%) reach immunocytochemistry-grade quality .
When performing Western blotting with BHLH149 antibodies, researchers may encounter several common issues that can be systematically addressed:
No Signal or Weak Signal:
Cause: Insufficient antibody concentration, protein degradation, inefficient transfer
Solution: Increase antibody concentration, add fresh protease inhibitors, optimize transfer conditions
Approach: Implement a gradient of antibody dilutions (1:250 to 1:2000) to determine optimal concentration
Multiple Bands:
Cause: Cross-reactivity with related BHLH proteins, protein degradation, non-specific binding
Solution: Increase blocking concentration, optimize washing steps, validate with knockout controls
Technique: Pre-absorb antibody with Arabidopsis total protein extract from bhlh149 mutant before use
High Background:
Cause: Insufficient blocking, excessive antibody concentration, inadequate washing
Solution: Extend blocking time, decrease antibody concentration, increase washing duration
Method: Test alternative blocking agents (5% BSA vs. non-fat milk) and TBST washing buffer with varying Tween-20 concentrations
Inconsistent Results:
Cause: Batch-to-batch variation in antibody preparation, inconsistent sample preparation
Solution: Use the same antibody lot for comparative experiments, standardize protein extraction protocols
Practice: Implement internal loading controls and normalize BHLH149 signal to total protein or housekeeping proteins
These troubleshooting approaches are consistent with best practices in plant antibody research, where optimization of experimental conditions significantly improves detection confidence .
Thorough validation of BHLH149 antibody specificity is essential for generating reliable research results:
Genetic Validation Approaches:
Knockout/knockdown comparison:
Compare signal between wild-type and bhlh149 mutant plant extracts
Signal should be absent or significantly reduced in mutant samples
Include heterozygous plants to demonstrate dose-response relationship
Overexpression validation:
Test antibody against samples from BHLH149 overexpression lines
Signal intensity should correlate with expression level
Compare native vs. tagged protein detection patterns
Biochemical Validation Methods:
Peptide competition assay:
Pre-incubate antibody with excess of immunizing peptide/protein
Should eliminate or significantly reduce specific signal
Use unrelated peptide as negative control
Mass spectrometry validation:
Perform immunoprecipitation followed by mass spectrometry
Confirm that pulled-down protein corresponds to BHLH149
Identify potential cross-reacting proteins
Cross-Reactivity Assessment:
Testing against related proteins:
Express and purify related BHLH family members
Test antibody reactivity against protein panel
Quantify relative binding affinity
This comprehensive validation strategy follows approaches that have demonstrated significant improvements in antibody specificity determination, particularly for plant research where traditional validation methods may be more challenging .
Various experimental parameters can significantly impact the performance of BHLH149 antibodies:
Buffer Composition Effects:
| Buffer Component | Optimal Range | Effect on Performance |
|---|---|---|
| pH | 7.2-7.6 | Affects antibody-antigen binding affinity |
| Salt (NaCl) | 100-150 mM | Higher concentrations reduce non-specific binding but may decrease signal |
| Detergent (Tween-20) | 0.05-0.1% | Reduces background but excess may disrupt specific binding |
| Blocking Protein | 3-5% | BSA may be superior to milk for phospho-specific detection |
Temperature Considerations:
Primary antibody incubation at 4°C overnight typically yields better signal-to-noise ratio
Room temperature incubations (1-2 hours) may be sufficient but increase background
Higher temperatures (37°C) are generally not recommended for plant antibodies
Incubation Time Impact:
Extended primary antibody incubation (16-24 hours) often improves sensitivity
Secondary antibody incubation is optimal at 1-2 hours at room temperature
Washing steps should be at least 3 × 5 minutes with gentle agitation
Sample Preparation Factors:
Fresh tissue extraction generally yields better results than frozen material
Denaturing conditions (SDS, heat) may expose epitopes that are hidden in native conditions
Different extraction buffers may solubilize BHLH149 with varying efficiency
These experimental considerations align with observed performance variations in plant antibody studies, where methodological optimization significantly impacts detection success rates .
When BHLH149 antibodies fail to deliver expected results, researchers have several alternative approaches:
Alternative Detection Strategies:
Epitope tagging approaches:
Generate transgenic plants expressing tagged BHLH149 (HA, FLAG, MYC tags)
Use commercially validated tag antibodies for detection
Consider the impact of tags on protein function and localization
Fluorescent protein fusions:
Create BHLH149-GFP/RFP fusion constructs under native promoter
Use for in vivo localization and dynamics studies
Validate functionality of fusion proteins by complementation tests
Indirect Detection Methods:
RNA-based approaches:
RT-qPCR for transcript level analysis as proxy for protein expression
RNA in-situ hybridization for tissue-specific expression patterns
RNA-seq for global expression profiling
Interactome studies:
Yeast two-hybrid screening to identify interaction partners
Tandem affinity purification followed by mass spectrometry
Proximity labeling approaches (BioID, APEX)
Alternative Antibody Options:
Custom antibody development:
Design multiple immunogens targeting different regions of BHLH149
Consider different host species to overcome potential immunogenic constraints
Implement rigorous affinity purification strategies
Cross-reactive antibody utilization:
Test antibodies against closely related BHLH proteins
Validate specificity in your experimental system
Use in combination with genetic approaches for confirmation
These alternative approaches reflect the need for adaptability in plant molecular biology research, where success rates with antibody-based detection can be variable and may require complementary methodologies .
BHLH149 antibodies can serve as valuable tools within integrated multi-omics research frameworks:
Proteomics Integration:
Use for validation of mass spectrometry-identified BHLH149 peptides
Employ in targeted proteomics approaches (SRM/MRM) for quantification
Apply in immunoprecipitation followed by mass spectrometry to identify protein complexes
Correlate protein abundance with transcript levels from transcriptomics
Functional Genomics Applications:
Validate knockout/knockdown efficiency at protein level
Assess protein abundance changes in various mutant backgrounds
Correlate phenotypic alterations with protein expression patterns
Monitor protein expression in response to environmental stimuli
Systems Biology Framework:
Map BHLH149 protein localization data to interaction networks
Integrate protein expression data with metabolomic profiles
Use for validation of computational predictions of protein function
Apply in time-series experiments to capture dynamic protein behavior
This integrated approach to utilizing antibodies aligns with current systems biology frameworks that aim to model multi-cellular systems using comprehensive data integration, where protein localization and interaction data are crucial components .
Several cutting-edge techniques could expand the applications of BHLH149 antibodies in plant molecular biology:
Advanced Microscopy Approaches:
Super-resolution microscopy:
STORM/PALM techniques for nanoscale localization
Structured illumination microscopy (SIM) for improved resolution
Expansion microscopy for physical sample enlargement
Live cell imaging optimization:
Antibody fragment (Fab) labeling of proteins in living cells
Nanobody development against BHLH149 for reduced size and improved penetration
SNAP/CLIP-tag systems for pulse-chase protein dynamics
Novel Biochemical Methods:
Proximity-dependent methods:
Antibody-based BioID/TurboID for identifying neighboring proteins
APEX-based proximity labeling for ultrastructural localization
Split antibody complementation for protein-protein interaction studies
Single-cell approaches:
Antibody-based single-cell proteomics
Mass cytometry (CyTOF) adaptation for plant cells
Spatial transcriptomics combined with protein detection
Computational Enhancement:
AI-assisted image analysis:
Machine learning algorithms for automated protein localization
Pattern recognition for subtle expression changes
Quantitative image analysis across large datasets
Integrative modeling:
Prediction of antibody binding sites through structural modeling
Epitope prediction algorithms for improved antibody design
In silico screening of potential cross-reactivity
These emerging techniques represent the frontier of plant molecular biology research, where improved tools for protein detection and localization are critical for advancing our understanding of complex cellular systems .
Distinguishing between BHLH149 isoforms or post-translationally modified variants requires specialized approaches:
Isoform Differentiation Strategies:
Isoform-specific antibody development:
Design peptides spanning unique exon junctions
Target isoform-specific regions for immunization
Validate using overexpression of specific isoforms
Electrophoretic resolution:
Use Phos-tag™ SDS-PAGE to separate phosphorylated forms
Employ high-percentage gels for separating small size differences
Implement 2D gel electrophoresis (isoelectric focusing + SDS-PAGE)
Post-translational Modification Detection:
Modification-specific antibodies:
Phospho-specific antibodies if phosphorylation sites are known
Ubiquitin/SUMO modification detection using co-immunoprecipitation
Glycosylation detection using lectins combined with antibody detection
Enzymatic treatments:
Phosphatase treatment to collapse phosphorylated forms
Deglycosylation enzymes to remove sugar modifications
Comparison of mobility shifts before and after treatment
Combined Analytical Approaches:
Mass spectrometry integration:
Immunoprecipitation followed by targeted MS
Parallel reaction monitoring for specific modification sites
SILAC labeling for quantitative comparisons
Cellular fractionation:
Nuclear vs. cytoplasmic extraction to identify location-specific forms
Detergent solubility fractionation for membrane-associated variants
Chromatin fractionation for DNA-bound transcription factor
These methodological approaches build upon established techniques in protein biochemistry adapted to the challenges of plant proteins, where post-translational modifications often play critical roles in regulating transcription factor activity .
Investigating BHLH149 protein-protein interactions requires careful experimental design and consideration of several factors:
Antibody-Based Interaction Studies:
Co-immunoprecipitation optimization:
Test different lysis buffers to preserve protein complexes
Optimize antibody concentration and incubation conditions
Consider crosslinking to stabilize transient interactions
Include appropriate negative controls (IgG, knockout extracts)
Proximity ligation assay (PLA) adaptation:
Requires antibodies raised in different species
Optimize fixation to preserve protein complexes
Validate antibody specificity in the PLA context
Include appropriate controls for signal specificity
Complementary Approaches:
Yeast-based methods:
Yeast two-hybrid screening or validation
Split-ubiquitin systems for membrane-associated interactions
Consider potential plant-specific cofactors or modifications
In planta validation techniques:
Bimolecular fluorescence complementation (BiFC)
Förster resonance energy transfer (FRET)
Split luciferase complementation assays
Technical Considerations:
Sample preparation critical factors:
Timing of harvest (developmental stage, diurnal regulation)
Tissue specificity (where BHLH149 is natively expressed)
Environmental conditions that may affect interactions
Crosslinking protocols to capture transient interactions
Data analysis considerations:
Quantitative assessment of interaction strength
Competition assays to determine binding hierarchies
Domain mapping to identify interaction interfaces
Correlation with functional outcomes
These methodological considerations draw from successful approaches in plant protein interaction studies, where careful optimization of experimental conditions is crucial for detecting authentic interactions, particularly for transcription factors that often form dynamic regulatory complexes .
Current research with BHLH149 antibodies faces several limitations that future developments may address:
Current Technical Limitations:
Limited validation for applications beyond ELISA and Western blotting
Potential cross-reactivity with related BHLH family members
Challenges in detecting low-abundance transcription factors in planta
Polyclonal nature introducing batch-to-batch variability
Limited sensitivity for detecting post-translational modifications
Promising Future Developments:
Antibody engineering advancements:
Development of monoclonal antibodies for improved consistency
Recombinant antibody technology for renewable reagents
Single-domain antibodies (nanobodies) for improved tissue penetration
Modification-specific antibodies for studying regulation
Technological innovations:
Microfluidic antibody screening for improved specificity
AI-assisted epitope prediction for better immunogen design
CRISPR-based tagging for endogenous protein detection
Advances in proteomics requiring less starting material
Integration with emerging methods:
Spatial proteomics for tissue-specific detection
Single-cell protein profiling technologies
High-throughput functional screening platforms
Improved computational prediction of antibody specificity
These future directions align with the broader trend in plant antibody research toward more reliable, specific, and versatile immunological tools that can support increasingly sophisticated systems biology approaches .
BHLH149 antibodies represent one of several complementary approaches for studying plant transcription factors, each with distinct advantages and limitations:
Comparative Analysis of Methods:
| Approach | Advantages | Limitations | Complementarity with Antibodies |
|---|---|---|---|
| Antibody Detection | Detects endogenous protein; Can reveal PTMs; Quantitative potential | Cross-reactivity concerns; Technical variability; Limited spatial resolution | - |
| Fluorescent Protein Tagging | Live imaging possible; Dynamics studies; Good spatial resolution | Potential tag interference; Overexpression artifacts; Limited PTM detection | Validate antibody specificity; Confirm localization patterns |
| Transcriptomics | Global expression patterns; High sensitivity; Well-established protocols | RNA≠protein levels; No PTM information; Limited spatial resolution | Correlate protein with transcript levels; Validate expression patterns |
| ChIP-seq | Identifies DNA binding sites; Genome-wide coverage; Functional insights | Requires quality antibodies; High background concerns; Technical complexity | Provide antibodies for ChIP; Validate binding to predicted targets |
| Proteomics | Unbiased detection; PTM mapping; Interaction discovery | Low sensitivity for rare proteins; Complex sample preparation; Expensive | Validate mass spec identifications; Enrich low-abundance proteins |
Integration Strategy:
The most effective research approach combines multiple methods, using antibodies for:
Validating findings from other techniques
Providing quantitative protein information
Detecting specific protein modifications
Examining endogenous expression patterns
This comparative perspective highlights the complementary nature of different research tools and emphasizes the continued value of well-validated antibodies in the plant molecular biology toolkit, particularly as we move toward more integrative understanding of complex biological systems .
When interpreting results from experiments utilizing BHLH149 antibodies, researchers should consider several important factors:
Technical Interpretation Considerations:
Antibody validation thoroughness:
Extent of specificity testing performed
Controls included in the experiment
Cross-reactivity potential with related proteins
Batch-to-batch variability in polyclonal preparations
Signal interpretation nuances:
Background signal versus specific detection
Quantitative limitations of Western blotting
Sensitivity thresholds for detecting low-abundance proteins
Potential for non-specific bands in complex plant extracts
Biological Context Factors:
Physiological relevance:
Expression levels relative to natural abundance
Developmental timing and tissue specificity
Environmental conditions affecting expression
Relationship to known BHLH149 functions
Regulatory considerations:
Post-translational modifications affecting detection
Protein complex formation masking epitopes
Protein turnover and stability factors
Subcellular compartmentalization affecting extraction
Data Integration Challenges:
Correlation with other data types:
Consistency with transcript expression patterns
Agreement with genetic phenotypes
Alignment with predicted protein function
Integration with interaction network data
Reproducibility assessment:
Biological versus technical replicates
Statistical analysis of quantitative data
Independent validation through complementary approaches
Publication of negative or inconsistent results
Advances in plant antibody technology, including improvements in BHLH149 antibodies, have the potential to significantly impact the broader field of plant biology:
Transformative Research Impacts:
Systems biology advancement:
More accurate protein localization data for network modeling
Better quantification of protein dynamics in response to stimuli
Improved understanding of protein-protein interaction networks
Integration of protein-level data with other omics approaches
Functional genomics acceleration:
Faster validation of gene function at protein level
More precise characterization of mutant phenotypes
Improved understanding of protein regulation mechanisms
Better tools for studying protein families and redundancy
Methodological Paradigm Shifts:
Standardization improvements:
Development of community-wide antibody validation standards
Creation of comprehensive plant antibody repositories
Improved reproducibility across laboratories
Better research resource allocation through validated reagents
Technological transfer:
Adaptation of medical antibody technologies to plant research
Development of plant-specific immunological techniques
Creation of multiplex detection systems for plant proteins
AI-assisted antibody design and validation
Future Research Directions:
Addressing fundamental questions:
Protein complex composition in developmental pathways
Transcription factor dynamics during environmental responses
Post-translational modification networks in signaling
Spatial and temporal protein distribution in plant development
Applied research acceleration:
Crop improvement through better protein characterization
Stress tolerance mechanisms at protein level
Plant-pathogen interaction studies with improved tools
Synthetic biology applications with better characterized components